(Q37993070)

26 August 2017

1 reference

title

Systemic sclerosis: is there a treatment yet? (English)

1 reference

26 August 2017

Black CM

1

1 reference

PMC publication ID

1004218

26 August 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

Annals of the Rheumatic Diseases

26 August 2017

1 reference

26 August 2017

49

1 reference

26 August 2017

9

1 reference

26 August 2017

735-737

1 reference

Plasma exchange: a controlled study of the effect in patients with Raynaud's phenomenon and scleroderma

26 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

A new promising treatment in systemic sclerosis: 5-fluorouracil

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

Treatment of systemic sclerosis in 1988.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

Scleroderma treated with immunosuppressive drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

Cyclosporine in successful control of rapidly progressive scleroderma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

Recombinant interferon-gamma in the treatment of systemic sclerosis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

Controlled trial of plasma exchange in treatment of Raynaud's syndrome

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004218

Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin

23 June 2018

1 reference

12 December 2020

Cyclosporin A in systemic sclerosis

1 reference

12 December 2020

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study

1 reference

12 December 2020

Treatment of systemic sclerosis

1 reference

12 December 2020

Lack of clinical benefit after treatment of systemic sclerosis with total lymphoid irradiation

1 reference

12 December 2020

THIOGUANINE IN THE TREATMENT OF CERTAIN AUTOIMMUNE, IMMUNOLOGIC AND RELATED DISEASES

1 reference

12 December 2020

Clinical effectiveness of apheresis in the treatment of progressive systemic sclerosis

1 reference

12 December 2020

[Generalized scleroderma. Treatment with immunosuppressive agents]

1 reference

12 December 2020

Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma)

1 reference

12 December 2020

The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases

1 reference

12 December 2020

Plasmapheresis and immunosuppressive drug therapy in scleroderma

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.49.9.735

1 reference

26 August 2017

1 reference

PMC publication ID

1004218

26 August 2017

PubMed publication ID

2241296

1 reference

PMC publication ID

1004218